About Iomai Corporation
Iomai Corporation is a company based in Gaithersburg (United States) founded in 1997 was acquired by Intercell in May 2008.. Iomai Corporation has raised $54 million across 1 funding round from investors including Intercell, CDIB Capital Group and NEA. Iomai Corporation offers products and services including Dissertation Writing Guides and Mentorship Advice. Iomai Corporation operates in a competitive market with competitors including Serum Institute of India, Vaxcyte, HOOKIPA Pharma, Vir Biotechnology and Biological E, among others.
- Headquarter Gaithersburg, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Iomai Corporation
Iomai Corporation offers a comprehensive portfolio of products and services, including Dissertation Writing Guides and Mentorship Advice. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides tips for organizing committees and writing chapters effectively.
Offers strategies for selecting professors and alleviating anxiety.
Funding Insights of Iomai Corporation
Iomai Corporation has successfully raised a total of $54M through 1 strategic funding round. The most recent funding activity was a Series C round of $54 million completed in January 2003. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $54.0M
-
First Round
First Round
(03 Jan 2003)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2003 | Amount | Series C - Iomai Corporation | Valuation | New Enterprise Associates , EW Healthcare Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Iomai Corporation
Iomai Corporation has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include Intercell, CDIB Capital Group and NEA. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Iomai Corporation
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Iomai Corporation
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Iomai Corporation Comparisons
Competitors of Iomai Corporation
Iomai Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Serum Institute of India, Vaxcyte, HOOKIPA Pharma, Vir Biotechnology and Biological E, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Vaccines and immuno-biological drugs for infectious diseases are manufactured.
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Iomai Corporation
When was Iomai Corporation founded?
Iomai Corporation was founded in 1997 and raised its 1st funding round 6 years after it was founded.
Where is Iomai Corporation located?
Iomai Corporation is headquartered in Gaithersburg, United States. It is registered at Gaithersburg, Maryland, United States.
Is Iomai Corporation a funded company?
Iomai Corporation is a funded company, having raised a total of $54M across 1 funding round to date. The company's 1st funding round was a Series C of $54M, raised on Jan 03, 2003.
What does Iomai Corporation do?
Founded in 1997 in Gaithersburg, United States, Iomai Corporation is engaged in the biotechnology sector, focusing on vaccines and immune system stimulants. Needle-free transcutaneous immunization technology is utilized to target antigen-presenting cells in the skin for enhanced responses. Existing vaccines are improved in efficacy, and new transcutaneous administration options are enabled. Following acquisition by Intercell, operations were restructured as a subsidiary under Intercell Biomedical Research Development AG.
Who are the top competitors of Iomai Corporation?
Iomai Corporation's top competitors include Vaxcyte, HOOKIPA Pharma and Serum Institute of India.
What products or services does Iomai Corporation offer?
Iomai Corporation offers Dissertation Writing Guides and Mentorship Advice.
Who are Iomai Corporation's investors?
Iomai Corporation has 8 investors. Key investors include Intercell, CDIB Capital Group, NEA, MedImmune Ventures, and Domain Associates.